Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1967 1
1973 1
1978 1
1979 4
1980 1
1981 4
1982 2
1983 4
1985 2
1986 1
1987 2
1988 4
1989 2
1990 1
1991 1
1992 4
1994 3
1995 2
1996 2
1997 2
1998 2
1999 4
2000 5
2002 5
2003 6
2004 10
2005 13
2006 7
2007 18
2008 15
2009 17
2010 37
2011 42
2012 51
2013 60
2014 41
2015 35
2016 52
2017 50
2018 83
2019 79
2020 128
2021 143
2022 151
2023 148
2024 34

Text availability

Article attribute

Article type

Publication date

Search Results

1,116 results

Results by year

Filters applied: . Clear all
Page 1
CXCR2 inhibition enables NASH-HCC immunotherapy.
Leslie J, Mackey JBG, Jamieson T, Ramon-Gil E, Drake TM, Fercoq F, Clark W, Gilroy K, Hedley A, Nixon C, Luli S, Laszczewska M, Pinyol R, Esteban-Fabró R, Willoughby CE, Haber PK, Andreu-Oller C, Rahbari M, Fan C, Pfister D, Raman S, Wilson N, Müller M, Collins A, Geh D, Fuller A, McDonald D, Hulme G, Filby A, Cortes-Lavaud X, Mohamed NE, Ford CA, Raffo Iraolagoitia XL, McFarlane AJ, McCain MV, Ridgway RA, Roberts EW, Barry ST, Graham GJ, Heikenwälder M, Reeves HL, Llovet JM, Carlin LM, Bird TG, Sansom OJ, Mann DA. Leslie J, et al. Among authors: mohamed ne. Gut. 2022 Apr 27;71(10):2093-106. doi: 10.1136/gutjnl-2021-326259. Online ahead of print. Gut. 2022. PMID: 35477863 Free PMC article.
A phase III, randomized, open-label study (CONTACT-02) of cabozantinib plus atezolizumab versus second novel hormone therapy in patients with metastatic castration-resistant prostate cancer.
Agarwal N, Azad A, Carles J, Chowdhury S, McGregor B, Merseburger AS, Oudard S, Saad F, Soares A, Benzaghou F, Kerloeguen Y, Kimura A, Mohamed N, Panneerselvam A, Wang F, Pal S. Agarwal N, et al. Among authors: mohamed n. Future Oncol. 2022 Mar;18(10):1185-1198. doi: 10.2217/fon-2021-1096. Epub 2022 Jan 17. Future Oncol. 2022. PMID: 35034502 Free article.
COVID-19 in Sudan.
Ahmed A, Mohamed NS, El-Sadig SM, Fahal LA, Abelrahim ZB, Ahmed ES, Siddig EE. Ahmed A, et al. Among authors: mohamed ns. J Infect Dev Ctries. 2021 Mar 7;15(2):204-208. doi: 10.3855/jidc.14520. J Infect Dev Ctries. 2021. PMID: 33690201 Free article.
SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination.
Liew F, Talwar S, Cross A, Willett BJ, Scott S, Logan N, Siggins MK, Swieboda D, Sidhu JK, Efstathiou C, Moore SC, Davis C, Mohamed N, Nunag J, King C, Thompson AAR, Rowland-Jones SL, Docherty AB, Chalmers JD, Ho LP, Horsley A, Raman B, Poinasamy K, Marks M, Kon OM, Howard L, Wootton DG, Dunachie S, Quint JK, Evans RA, Wain LV, Fontanella S, de Silva TI, Ho A, Harrison E, Baillie JK, Semple MG, Brightling C, Thwaites RS, Turtle L, Openshaw PJM; ISARIC4C Investigators; PHOSP-COVID collaborative group. Liew F, et al. Among authors: mohamed n. EBioMedicine. 2023 Jan;87:104402. doi: 10.1016/j.ebiom.2022.104402. Epub 2022 Dec 19. EBioMedicine. 2023. PMID: 36543718 Free PMC article.
Could antiseptic gargling prevent COVID-19?
Mohamed NA, Ahmad Zainol Hady A, Abdul Aziz AH, Isahak I. Mohamed NA, et al. Trop Biomed. 2020 Dec 1;37(4):1141-1145. doi: 10.47665/tb.37.4.1141. Trop Biomed. 2020. PMID: 33612766 Review.
The spectrum of indomethacin-responsive headaches in children and adolescents.
Myers KA, Barmherzig R, Raj NR, Berrahmoune S, Ingelmo P, Saint-Martin C, Khan AQ, Kouri M, Morris C, Hershey AD, Kacperski J, Kabbouche MA, Mohamed N, Rao RR, Lagman-Bartolome AM, Gelfand AA, Szperka CL, Orr SL. Myers KA, et al. Among authors: mohamed n. Cephalalgia. 2022 Jul;42(8):793-797. doi: 10.1177/03331024221076483. Epub 2022 Mar 18. Cephalalgia. 2022. PMID: 35302385 Free PMC article. Review.
SARS-CoV-2: The Path of Prevention and Control.
Mohamed AA, Mohamed N, Mohamoud S, Zahran FE, Khattab RA, El-Damasy DA, Alsayed E, Abd-Elsalam S. Mohamed AA, et al. Among authors: mohamed n. Infect Disord Drug Targets. 2021;21(3):358-362. doi: 10.2174/1871526520666200520112848. Infect Disord Drug Targets. 2021. PMID: 32433010 Review.
Nanomedicine as a Potential Tool against Monkeypox.
Mohamed NA, Zupin L, Mazi SI, Al-Khatib HA, Crovella S. Mohamed NA, et al. Vaccines (Basel). 2023 Feb 13;11(2):428. doi: 10.3390/vaccines11020428. Vaccines (Basel). 2023. PMID: 36851305 Free PMC article. Review.
1,116 results